Cristiana Oprea - Infectious Diseases

Author Information

Dr. Cristiana Oprea is affiliated with the Victor Babes Hospital for Infectious and Tropical Diseases and the Carol Davila University of Medicine and Pharmacy, both located in Bucharest, Romania. Her work primarily revolves around infectious diseases, with a focus on viral infections and their implications for patients with co-morbidities such as HIV.

Research Contributions

Dr. Oprea has made significant contributions to the field of infectious diseases, particularly in understanding the complexities of viral co-infections and their management. Her research spans several critical areas, including the study of Hepatitis B and C in HIV-positive individuals, the impact of COVID-19 in the same population, and the interactions between various treatments. Her work provides valuable insights into the challenges faced by healthcare providers in managing patients with multiple concurrent infections and the need for integrated therapeutic strategies.

Aliases

Dr. Oprea is also known by several aliases including C Oprea, C Opréa, and Cristian Oprea. These variations are often encountered in academic publications and professional settings.

Publication and Citation Metrics

Metric	Value
Citation Count	595
H-index	13
Paper Count	76

Publications:

Hepatitis B Virus Genotypes and Antiviral Resistance Mutations in Romanian HIV-HBV Co-Infected Patients

DOI: 10.3390/medicina58040531

Year: 2022

The Presence of Both Typical or Atypical Radiological Changes Predicts Poor COVID-19 Outcomes in HIV-Positive Patients From a Multinational Observational Study: Data From Euroguidelines in Central and Eastern Europe Network Group

DOI: 10.2139/ssrn.4022244

Year: 2022

Medical nutrition therapeutic approach of non-alcoholic fatty liver: diet, nutraceuticals, phytotherapy and probiotics

DOI: 10.54448/ijn21401

Year: 2021

Cerebrospinal Fluid viral load across the spectrum of untreated HIV-1 infection: a cross-sectional multi-center study.

DOI: 10.1093/cid/ciab943

Year: 2021

Exploring and understanding HCV patient journeys- HEPCARE Europe project

DOI: 10.1186/s12879-021-05928-9

Year: 2021

Retrospective evaluation of an observational cohort by the Central and Eastern Europe Network Group shows a high frequency of potential drug-drug interactions among HIV-positive patients receiving treatment for coronavirus disease 2019 (COVID-19).

DOI: 10.1111/hiv.13214

Year: 2021

Contemporary antiretrovirals and body-mass index: a prospective study of the RESPOND cohort consortium.

DOI: 10.1016/S2352-3018(21)00163-6

Year: 2021

National strategies for vaccination against COVID‐19 in people living with HIV in Central and Eastern European region

DOI: 10.1111/hiv.13194

Year: 2021

Where are we with pre‐exposure prophylaxis use in Central and Eastern Europe? Data from the Euroguidelines in Central and Eastern Europe (ECEE) Network Group

DOI: 10.1111/hiv.12960

Year: 2020

Influence of Hepatitis C Coinfection and Treatment on Risk of Diabetes Mellitus in HIV-Positive Persons

DOI: 10.1093/ofid/ofaa470

Year: 2020

How is Strep Throat Diagnosed?

How Can Individuals Contribute to One Health?

What are Natural Killer (NK) Cells?

What Role Do Metabolic Pathways Play in Antibiotic Resistance?

What is the Treatment for Gonorrhea?

How Do ID Specialists Stay Updated?

What Role Does Technology Play in Infectious Disease Education?

When to Seek Medical Attention?

What are the controversies surrounding Dengvaxia?

What is Community Hygiene and its Importance?

Partnered Content Networks

Relevant Topics